ACT001 inhibits the proliferation of non ‐small cell lung cancer cells by upregulating NKTR expression

ConclusionOur results suggested NKTR may be the target of ACT001 in NSCLC. ACT001 holds promise as a novel method for the treatment of NSCLC.

Source: Thoracic Cancer - May 11, 2022 Category: Cancer & Oncology Authors: Min Zhao, Tingting Qin, Dingzhi Huang Tags: ORIGINAL ARTICLE Source Type: research